Please use this identifier to cite or link to this item:
|Title:||Evaluating available pharmacist-recommended medicines for paediatric patients|
Attard Pizzuto, Maresca
Azzopardi, Lilian M.
|Keywords:||Pharmacist and patient|
Pharmaceutical services -- Standards
Pharmacy -- Practice
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Baldacchino, C., Attard Pizzuto, M., & Azzopardi, L. M. (2020). Evaluating available pharmacist-recommended medicines for paediatric patients. FIP Virtual Event : Living and Learning Through the Covid-19 Pandemic - Global Reflections.|
|Abstract:||Pediatrics are most of the time defined as 'therapeutic orphans' as there is limited knowledge on the pharmacokinetic and pharmacodynamic properties of drugs in the population. Moreover, there are constraints in formulations that are accessible to pediatric patients including dosage from route of administration characteristics. Availability and scientific data for products that may be recommended by pharmacists upon presentation of symptoms for pediatrics varies. Pharmacists play extensive role as highly accessible primary health care workers who can provide information regarding medicines use in the pediatric population particularly related to management of minor symptoms. Against this background community pharmacists require access to pharmacokinetic and pharmacodynamics data of medicines to be able to guide evidence-based use of medicines in the pediatric population.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Baldacchino - Evaluating Available Pharmacist-Recommended Medicines for Paediatric Patients.pdf||608.6 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.